# AUROPHARMA share price, delivery % and history — Aurobindo Pharma Limited

> Delivery percentage for Aurobindo Pharma Limited (AUROPHARMA) against its own history, with 7,573 sessions of split-adjusted NSE data from 1995 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/AUROPHARMA

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 1,672 INR (-1.51% on the day), 2026-09-30
- Delivery: 51.09% of volume taken to demat (20-day average 49.62%)
- Volume: 11.39L shares, turnover ₹190.4Cr
- Relative volume: 1.44× of its own 20-day average

## Technicals

- RSI(14): 49.32
- ATR(14): 37.5
- SMA 50: 1,640.93, SMA 200: 1,412.3
- 52-week range: 1,066.8 – 1,740 (-3.91% from the high)

## Performance

- 1 week -2.88%, 1 month -2.62%, 3 months 7.11%
- 6 months 27.23%, 1 year 50.64%

## Delivery percentage

- Latest: 51.09% (2026-09-30)
- 20-day average: 49.62%
- 1-year average: 48.24%
- Percentile against its own history: 82th
- Range: 6.5% – 78.11% across 1,728 sessions with a reading

Over the last 20 sessions AUROPHARMA settled 49.6% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 48.2%. The latest session ranks higher than 82% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 96,203.2 crore
- P/E (TTM): 25.93 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 64.49 INR, split-adjusted to match the price series
- Revenue growth: 16.3% YoY, 3.35% QoQ
- Profit growth: 25.22% YoY, 12.07% QoQ

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 7,796.1 | 6,724.9 | 1,207.2 | 817 | 14 | 10.48% |
| 2024-12-31 | 7,978.5 | 6,937.6 | 1,198.3 | 845.6 | 14.56 | 10.6% |
| 2025-03-31 | 8,382.1 | 7,149.7 | 1,367.3 | 902.8 | 15.56 | 10.77% |
| 2025-06-30 | 7,868.1 | 6,768.6 | 1,204.9 | 824.2 | 14.2 | 10.48% |
| 2025-09-30 | 8,285.7 | 7,132 | 1,274.3 | 848.1 | 14.61 | 10.24% |
| 2025-12-31 | 8,645.9 | 7,430.1 | 1,338.2 | 909.8 | 15.67 | 10.52% |
| 2026-03-31 | 8,853.3 | 7,677.3 | 1,293 | 920.8 | 15.86 | 10.4% |
| 2026-06-30 | 9,150.4 | 7,857.8 | 1,516.6 | 1,032 | 17.86 | 11.28% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 51.88%
- Public: 48.12%
- FII: 16.38%, DII: 25.1%
- Promoter shares pledged: 13.75%

## Recent filings

- 2026-08-05: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_182938_05082026211304_iXBRL_WEB.html
- 2026-07-15: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1693124_15072026033059_WEB.xml
- 2026-05-21: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_159969_21052026221250_iXBRL_WEB.html
- 2026-04-17: buyback
- 2026-04-17: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1653158_17042026040030_WEB.xml
- 2026-02-09: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141438_09022026211010_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1599979_13012026051655_WEB.xml
- 2025-11-05: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124680_05112025214524_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 139 events are indexed for this instrument.

## About the instrument

- Listed: 1995-10-19 — latest session 2026-09-30 (7,573 sessions)
- ISIN: INE406A01037
- Series: EQ
- Liquidity rank: #227 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/AUROPHARMA.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.